Today's Veterinary Practice

JAN-FEB 2018

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: https://todaysveterinarypractice.epubxp.com/i/919967

Contents of this Issue

Navigation

Page 84 of 101

IMPORTANT SAFETY INFORMATION: NexGard ® (afoxolaner) is for use in dogs only. The most frequently reported adverse reactions included pruritus, vomiting, dry/fl aky skin, diarrhea, lethargy, and lack of appetite. The safe use of NexGard in pregnant, breeding, or lactating dogs has not been evaluated. Use with caution in dogs with a history of seizures. For more information, see full prescribing information or visit www.NexGardForDogs.com. NexGard is a Merial product. Merial is now part of Boehringer Ingelheim. NexGard ® is a registered trademark, and FRONTLINE VET LABS TM is a trademark, of Merial. ©2017 Merial, Inc., Duluth, GA. All rights reserved. NEX18TRADEAD1 (01/18). Make killing fl eas & ticks Preferred by dogs 1 and dog owners 2 – NexGard® (afoxolaner) makes it easy to protect your canine patients against fl eas and four of the most common species of ticks in North America. 1 Data on fi le at Merial. 2 Data on fi le at Merial. Based on veterinary dispensed dose data.

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Practice - JAN-FEB 2018